Articles

As an oncology specialist, I find that this is sometimes one of the hardest questions to answer. Not because we do not have scans, blood tests, and treatment protocols. We do.

Immunotherapy is something that comes up more and more when discussing cancer treatment, often as a newer option or something that sounds promising on paper.

When most people hear the word “radiotherapy”, they picture weeks of daily hospital visits. Tiredness builds up. Life put on hold. For a long time, that was an accurate picture.

Radiotherapy has been part of cancer treatment for decades. Most people have a general sense of what it involves. High-energy beams. Targeting a tumour. A course of treatment over several weeks.

When people think about lung cancer, symptoms such as cough, breathlessness, or chest discomfort usually come to mind.

This is usually not an abstract question. People ask it because something has just happened: A scan. A biopsy. A sentence that included the words “small cell”.

Back pain is one of the most common reasons people see a GP. Most of the time, it is muscular, postural, or due to wear and tear. It’s most often something annoying rather than something sinister.

Prevention is a word that gets used a lot in medicine, and it carries some baggage.

When someone is diagnosed with lung cancer, one of the first concerns is often how quickly the disease may progress. The answer is not always straightforward.

When lung cancer is suspected, the question most people ask is fairly direct.
What tests confirm it?

Radiotherapy has been part of lung cancer treatment for a long time. For most of that time, the challenge has been the same. How do you deliver enough radiation to destroy a tumour without causing too much damage to the healthy tissue around it?

Lung cancer remains one of the most common cancers in the UK, with around 48,000 new diagnoses each year. It is also one of the leading causes of cancer-related death.